Planet Labs PBC Earnings Calls
| Release date | Sep 14, 2026 |
| EPS estimate | -$0.0200 |
| EPS actual | - |
| Revenue estimate | 104.241M |
| Revenue actual | - |
| Expected change | +/- 8.75% |
| Release date | Jun 04, 2026 |
| EPS estimate | -$0.0418 |
| EPS actual | -$0.0300 |
| EPS Surprise | 28.25% |
| Revenue estimate | 90.392M |
| Revenue actual | 94.15M |
| Revenue Surprise | 4.16% |
| Release date | Mar 19, 2026 |
| EPS estimate | -$0.0472 |
| EPS actual | -$0.480 |
| EPS Surprise | -916.73% |
| Revenue estimate | 78.199M |
| Revenue actual | 86.822M |
| Revenue Surprise | 11.03% |
| Release date | Dec 10, 2025 |
| EPS estimate | -$0.0335 |
| EPS actual | -$0.190 |
| EPS Surprise | -467.33% |
| Revenue estimate | 72.19M |
| Revenue actual | 81.254M |
| Revenue Surprise | 12.56% |
Last 4 Quarters for Planet Labs PBC
Below you can see how PL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Dec 10, 2025 |
| Price on release | $12.97 |
| EPS estimate | -$0.0335 |
| EPS actual | -$0.190 |
| EPS surprise | -467.33% |
| Date | Price |
|---|---|
| Dec 04, 2025 | $12.94 |
| Dec 05, 2025 | $12.77 |
| Dec 08, 2025 | $12.95 |
| Dec 09, 2025 | $12.83 |
| Dec 10, 2025 | $12.97 |
| Dec 11, 2025 | $17.45 |
| Dec 12, 2025 | $18.24 |
| Dec 15, 2025 | $18.05 |
| Dec 16, 2025 | $17.88 |
| 4 days before | 0.232% |
| 4 days after | 37.86% |
| On release day | 34.50% |
| Change in period | 38.18% |
| Release date | Mar 19, 2026 |
| Price on release | $26.96 |
| EPS estimate | -$0.0472 |
| EPS actual | -$0.480 |
| EPS surprise | -916.73% |
| Date | Price |
|---|---|
| Mar 13, 2026 | $24.79 |
| Mar 16, 2026 | $24.60 |
| Mar 17, 2026 | $27.08 |
| Mar 18, 2026 | $24.81 |
| Mar 19, 2026 | $26.96 |
| Mar 20, 2026 | $33.83 |
| Mar 23, 2026 | $33.82 |
| Mar 24, 2026 | $31.83 |
| Mar 25, 2026 | $35.37 |
| 4 days before | 8.75% |
| 4 days after | 31.19% |
| On release day | 25.48% |
| Change in period | 42.68% |
| Release date | Jun 04, 2026 |
| Price on release | $43.53 |
| EPS estimate | -$0.0418 |
| EPS actual | -$0.0300 |
| EPS surprise | 28.25% |
| Date | Price |
|---|---|
| May 29, 2026 | $51.14 |
| Jun 01, 2026 | $46.46 |
| Jun 02, 2026 | $48.09 |
| Jun 03, 2026 | $43.13 |
| Jun 04, 2026 | $43.53 |
| Jun 05, 2026 | $32.22 |
| Jun 08, 2026 | $32.74 |
| Jun 09, 2026 | $31.17 |
| Jun 10, 2026 | $30.72 |
| 4 days before | -14.88% |
| 4 days after | -29.43% |
| On release day | -25.98% |
| Change in period | -39.93% |
| Release date | Sep 14, 2026 |
| Price on release | - |
| EPS estimate | -$0.0200 |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $22.83 |
| Aug 05, 2026 | $22.35 |
| Aug 06, 2026 | $22.72 |
| Aug 07, 2026 | $23.93 |
| Aug 10, 2026 | $23.10 |
Planet Labs PBC Earnings Call Transcript Summary of Q2 2026
Planet Labs reported solid Q2 FY2026 results driven by strength in Defense & Intelligence and expanding satellite services. Key financials: revenue of $73.4M (+~20% YoY), non‑GAAP gross margin of 61% (up from 58% YoY), adjusted EBITDA profit of $6.4M (third consecutive profitable quarter), and year‑to‑date free cash flow of $54.3M (FCF margin ~39%). Backlog and RPOs expanded materially (backlog ~$736M, up ~245% YoY; RPOs ~$690M, up ~516% YoY), providing multi‑year revenue visibility. Planet highlighted strong demand and contract wins: a EUR 240M multiyear satellite services collaboration with Germany, a multiyear JSAT contract contribution, expanded EOCL work with the U.S. NRO, an additional Defense Innovation Unit option, and customer wins with NATO, U.S. DoD, SynMax (Germany partner), Farmdar, and Swiss Re. Operational progress: Pelican and Tanager satellite launches and ramped production (4 Pelicans in orbit, Pelican/Tanager commissioning underway); partnerships with Anthropic, Google, and NVIDIA to embed AI across product stack. Guidance: Q3 revenue $71M–$74M, non‑GAAP gross margin 55%–57%, adjusted EBITDA (Q3) -$4M to breakeven; FY revenue raised to $281M–$289M, non‑GAAP gross margin 55%–57%, adjusted EBITDA (FY) -$7M to breakeven, CapEx $65M–$75M. Management expects to be free cash flow positive for the fiscal year, ahead of prior targets. Risks noted: variability in government usage/timing, contract termination-for-convenience clauses in some U.S. federal contracts, and near‑term margin variability driven by revenue mix and satellite build phases.
Sign In
Buy PL